glp-1 agonist oral New Guidelines for Type 2 Diabetes in 2025 Recent advances and trends in

Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S

no major safety concerns were observed

22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.

Moreover, the addition of finerenone to this combination therapy could potentially provide stronger cardiorenal protective benefits

These steps can make it harder for some people to take the medicine regularly.What are compounded GLP-1 medications?Compounded GLP-1 medications are prepared by a pharmacist for each individual patient, sometimes at different doses or with different active forms of the drug than the FDA approved, brand-name medications

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes